|
|
A telehealth tDCS approach to decrease cannabis use: Towards reducing multiple sclerosis disability in multiple sclerosis |
| 1R21DA055427-01 |
|
NIDA |
2022 |
|
|
Psychostimulants, Attention Deficit and Basal Ganglia Disorders |
| 1R21DA055980-01 |
|
NIDA |
2022 |
|
|
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools |
| 1R21DA056293-01 |
|
NIDA |
2022 |
|
|
Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo |
| 5R01DA045596-05 |
|
NIDA |
2022 |
|
|
Physiological and Computational-Modeling Studies of Timbre Encoding in the Inferior Colliculus |
| 1F31DC020630-01A1 |
|
NIDCD |
2022 |
|
|
CI Neural Mechanisms |
| 1K23DC019970-01 |
|
NIDCD |
2022 |
|
|
Activity and Participation in Vestibulopathy |
| 1K23DC020215-01 |
|
NIDCD |
2022 |
|
|
A taxonomic articulation-focused approach to dysarthria classification |
| 1R01DC019648-01A1 |
|
NIDCD |
2022 |
|
|
Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors |
| 1R21DC019955-01 |
|
NIDCD |
2022 |
|
|
Parkinson’s disease biomarkers in human olfactory cleft mucus |
| 1R21DC020033-01 |
|
NIDCD |
2022 |
